MicroPulse Laser Therapy Reduced Eye Pressure
A two-year clinical study found significant pressure reduction in glaucoma patients using the MicroPulse laser treatment.
Updated on Oct. 12, 2026 in Stroke
Live Poll
Do you generally trust the findings of independent clinical studies for new medical treatment options?
The International Journal of Ophthalmology published research showing that MicroPulse laser therapy effectively lowered intraocular pressure. Patients experienced a sustained reduction in pressure and decreased reliance on daily medication over two years.
Why it matters
This study provides evidence for a less invasive, long-term glaucoma management strategy that may reduce the burden of daily topical medications. By maintaining stable visual fields, the procedure offers a potential alternative for patients struggling with traditional treatment adherence.
Researchers observed success rates of 86 percent for primary open-angle glaucoma and 81 percent for primary angle-closure glaucoma. Mean daily topical medication use dropped from 2.96 to 2.38 per patient by the end of the study.
The players
International Journal of Ophthalmology
This peer-reviewed publication serves as a primary source for medical research and clinical developments within the field of eye care.
Iridex
Headquartered in San Jose, California, this medical technology company specializes in the development of laser-based systems for ophthalmic treatments.
The details
The analysis evaluated the Iridex Cyclo G6 Laser with the MicroPulse P3 Delivery Device to manage patient intraocular pressure. During the study, researchers recorded stable visual field measurements with no observed complications or visual acuity loss.
Timeline
The clinical study follow-up period spanned 2024 to 2026.
Study findings were published on October 12, 2026.
Health Landscape
The use of the Iridex Cyclo G6 Laser with the MicroPulse P3 Delivery Device signals a shift in surgical glaucoma intervention. This study validates the long-term clinical application of this specific laser technology in managing the disease.
Patients may find that this laser treatment reduces their reliance on daily eye drops, simplifying their medication routine. Those interested in this procedure should consult with an ophthalmologist to discuss if the MicroPulse laser is an appropriate option for their specific type of glaucoma.
The takeaway
Clinical evidence now supports the effectiveness of MicroPulse laser therapy for maintaining stable eye pressure over two years. Patients currently managing glaucoma with multiple daily drops should discuss this laser intervention with their care team as a potential long-term alternative.
Further reading
Learn more about the latest research and management options for Stroke.
Live Poll
Do you generally trust the findings of independent clinical studies for new medical treatment options?
